The cBioPortal database, which contains publicly available genomic information, shows that harmful TP53 mutations are more common in patients with PCa carrying BRCA1 mutations than in patients carrying BRCA2 mutations (39% vs. 23%) (26). Here, BRCA1 is linked to posterior cortical atrophy.